DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance 由 Cyll, K, Skaaheim Haug, E, Pradhan, M, Vlatkovic, L, Carlsen, B, Löffeler, S, Kildal, W, Skogstad, K, Hauge Torkelsen, F, Syvertsen, RA, Askautrud, HA, Liestøl, K, Kleppe, A, Danielsen, HE